Information for "NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. (20240343772). Fusion protein and its preparation method for intermediate polypeptide of Semaglutide simplified abstract"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. (20240343772). Fusion protein and its preparation method for intermediate polypeptide of Semaglutide simplified abstract |
| Default sort key | NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. (20240343772). Fusion protein and its preparation method for intermediate polypeptide of Semaglutide simplified abstract |
| Page length (in bytes) | 4,701 |
| Page ID | 228536 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Wikipatents (talk | contribs) |
| Date of page creation | 00:56, 18 October 2024 |
| Latest editor | Wikipatents (talk | contribs) |
| Date of latest edit | 00:56, 18 October 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
